Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 10
Submit an article Journal homepage
121
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Octasomy 21 in a patient with secondary AML after CMML: the role of acquired NRAS mutations in triggering aneuploidy

Kathrin ThomayDepartment of Human Genetics, Hannover Medical School, Hannover, Germany
,
Yvonne Lisa BehrensDepartment of Human Genetics, Hannover Medical School, Hannover, Germany
,
Jana LentesDepartment of Human Genetics, Hannover Medical School, Hannover, Germany
,
Nicole WittnerDepartment of Human Genetics, Hannover Medical School, Hannover, Germany
,
Verena WittigDepartment of Human Genetics, Hannover Medical School, Hannover, Germany
,
Doreen RotheDepartment of Human Genetics, Hannover Medical School, Hannover, Germany
,
Doris SteinemannDepartment of Human Genetics, Hannover Medical School, Hannover, Germany
,
Brigitte SchlegelbergerDepartment of Human Genetics, Hannover Medical School, Hannover, Germany
&
Gudrun GöhringDepartment of Human Genetics, Hannover Medical School, Hannover, GermanyCorrespondence[email protected]
 show all
Pages 2478-2481 | Received 20 Nov 2017, Accepted 08 Jan 2018, Published online: 31 Jan 2018

References

  • Zandberg DP, Huang TY, Ke X, et al. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults. Haematologica. 2013;98:584–590.
  • Elena C, Galli A, Such E, et al. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016;128:1408–1417.
  • Courville EL, Wu Y, Kourda J, et al. Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia. Mod Pathol. 2013;26:751–761.
  • McGrattan P, Humphreys M, Hull D, et al. Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel +13, +15 double trisomy resulting in an adverse outcome. Ulster Med J. 2007;76:131–135.
  • Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–447.
  • Ripperger T, Tauscher M, Haase D, et al. Managing individuals with propensity to myeloid malignancies due to germline RUNX1 deficiency. Haematologica. 2011;96:1892–1894.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
  • Delhommeau F, Dupont S, Della Valle V, et al. Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360:2289–2301.
  • Meggendorfer M, Roller A, Haferlach T, et al. SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood. 2012;120:3080–3088.
  • Chang YI, Damnernsawad A, Allen LK, et al. Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation. Br J Haematol. 2014;166:461–465.
  • Kamata T, Pritchard C. Mechanisms of aneuploidy induction by RAS and RAF oncogenes. Am J Cancer Res. 2011;1:955–971.
  • Torres EM, Williams BR, Amon A. Aneuploidy: cells losing their balance. Genetics. 2008;179:737–746.
  • Hingorani SR, Wang L, Multani AS, et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005;7:469–483.
  • Luo J, Emanuele MJ, Li D, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell. 2009;137:835–848.
  • Tang YC, Williams BR, Siegel JJ, et al. Identification of aneuploidy-selective antiproliferation compounds. Cell. 2011;144:499–512.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.